HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF ETHANOL ROOT EXTRACT OF CLERODENDRUM PHLOMIDIS IN ALLOXAN-INDUCED DIABETIC RATS by Dinesh Shanbhag, Mrunal & Radhakrishnan, Gowri
Vol 11, Issue 11, 2018
Online - 2455-3891 
Print - 0974-2441
HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF ETHANOL ROOT EXTRACT OF 
CLERODENDRUM PHLOMIDIS IN ALLOXAN-INDUCED DIABETIC RATS
MRUNAL DINESH SHANBHAG, GOWRI RADHAKRISHNAN*
Department of Pharmacognosy, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India. 
Email: gowrijp@gmail.com
Received: 15 May 2018, Revised and Accepted: 21 July 2018
ABSTRACT
Objective: In traditional systems of medicine numerous plants have been used for the treatment and control of diabetes. Clerodendrum phlomidis 
is the accepted botanical source of the ayurvedic drug Agnimantha. The plant is used in the treatment of smallpox, inflammation, coryza, scrotal 
enlargement, syphilitic, and postnatal complaints. The roots are used to treat measles, gonorrhea, and diabetes. The present study aims at evaluating 
the hypoglycemic and hypolipidemic activity of C. phlomidis roots.
Methods: Diabetes was induced by administering 120 mg/kg alloxan monohydrate intraperitoneally in albino Wistar rats for a treatment period of 
21 days during which body weight changes and fasting blood glucose (FBG) were monitored at weekly intervals. On the 21st-day serum biochemical 
parameters, liver malondialdehyde, reduced glutathione, and glycogen levels were estimated.
Results: The ethanol extract at 400 mg/kg dose significantly (p<0.001) reduced the elevated FBG and serum biochemical parameter levels.
Conclusion: The present study substantiates the traditional use of C. phlomidis in the treatment of diabetes.
Keywords: Alloxan, Antidiabetic activity, Clerodendrum phlomidis, Hypolipidemic, Liver glycogen.
INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder affecting a large 
number of people in the world. Nearly 285 million people of the world 
population were known to be affected by diabetes in the year 2010, and 
this number may increase up to 439 million by 2030 [1]. This metabolic 
disorder occurs due to defects in insulin secretion and action. As the 
insulin secretion is hampered, it directly affects the action of insulin 
on glucose metabolism resulting in loss of homeostasis of glucose in 
the body. This also causes impaired metabolism of fats, carbohydrates, 
and proteins [2]. Diabetes mellitus is also characterized by glucosuria, 
ketonemia, hyperglycemia, and negative nitrogen balance which is 
caused due to deficiency of insulin [3].
Diabetes mellitus can be treated by improving the availability of 
insulin in the body and also by overcoming the resistance of insulin. 
To improve the insulin available to the body, drugs underclass of 
sulfonylurea, and meglitinide are used. Drugs belonging to biguanides, 
thiazolidinediones, and α-glucosidase inhibitors are used to overcome 
insulin resistance. Apart from these commercially available synthetic 
drugs diabetes can also be treated with herbal drugs. There is a great 
demand for a new ayurvedic based drug for diabetes in the developed 
and developing countries because of their wide biological activities 
and higher safety margin than the synthetic drugs. In Ayurveda, plants 
such as Phyllanthus amarus, Gymnema sylvestre, Trigonella foenum, 
Terminalia chebula, and Momordica charantia [4] are used in the 
management of diabetes mellitus.
Agnimantha is one of the important drugs in Ayurveda [5]. The 
accepted botanical source of Agnimantha is C. phlomidis L.f. belonging 
to the family Verbenaceae [6]. The plant is used in the treatment 
of smallpox, inflammation, coryza, scrotal enlargement, syphilitic, 
and postnatal complaints [7-9]. Roots are used in the treatment of 
measles, gonorrhea, diabetes, and as a bitter tonic [5]. Some species 
of Clerodendrum such as Clerodendrum serratum (leaves) [10], 
Clerodendrum viscosum (leaves) [11], and Clerodendrum inerme 
(aerial parts) [12] are reported for antidiabetic activity. C. phlomidis 
is traditionally used in the treatment of diabetes [13], but significant 
hypoglycemic and other pharmacological activities are reported on the 
leaves although root being the part of the plant used (crude drug). In 
a clinical trial, the hypoglycemic activity of C. phlomidis leaf was found 
to be effective compared to tolbutamide [13]. Since no work has been 
reported on the antidiabetic activity of C. phlomidis roots, the present 
study has been undertaken.
METHODS
Chemicals
Alloxan monohydrate was procured from Avra Synthesis Pvt, Ltd., 
Hyderabad, India, and all the reagent kits were obtained from Robonik 
Pvt. Ltd., Navi Mumbai, Maharashtra, India, and Diatek, Kolkata, India.
Plant material
The root of C. phlomidis was collected from Thoothukudi district of Tamil 
Nadu, India in January 2017. The plant was identified and authenticated 
by Dr. V. Chelladurai, Taxonomist. Herbarium of the plant material 
was prepared [14] and deposited in the herbarium of Department of 
Pharmacognosy, Faculty of Pharmacy, M. S. Ramaiah University of Applied 
Sciences, Bengaluru, Karnataka, India (Voucher specimen No. 052).
Preparation of ethanol extract
Total ethanol extract was prepared by extracting powdered crude drug 
with 95% ethanol by continuous hot percolation using Soxhlet apparatus. 
The extract was filtered and concentrated to dryness under reduced 
temperature and pressure. Preliminary phytochemical screening was 
performed for the detection of primary and secondary metabolites [15,16].
Determination of total phenolic and flavonoid content
The total phenolic content was determined by Folin–Ciocalteu method 
using gallic acid as standard [17] and total flavonoid content was 
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estimated by aluminum chloride colorimetric assay using Quercetin as 
a standard drug [18].
Animals
Healthy Albino Wistar rats of either sex weighing 200–300 g were 
used. The animals were housed in the Animal House of Department of 
Pharmacology, Faculty of Pharmacy, M. S. Ramaiah University of Applied 
Sciences, Bengaluru, Karnataka, India. All the animals had free access to 
food and water ad libitum and were kept under laboratory condition 
(12 h day and 12 h night cycle at 21±2°C). All diseased rats and those 
outside the weight range were excluded from the study. The study 
protocol was approved by the Institutional Animal Ethics Committee 
(IAEC No.: XVIII/MSRFPH/M-04/08.02.2017).
Acute toxicity study
Acute toxicity of ethanol root extract was determined as per the OECD 
guidelines 423. Limit test was performed by administering a dose of 
2000 mg/kg of ethanol extract to a group of 3 female animals. Animal 
behavior and toxicity signs were observed for 15 days and further until 
the end of the study [19].
Induction of diabetes
Diabetes was induced in the experimental animals by administering a single 
dose of 120 mg/kg body weight of alloxan monohydrate intraperitoneally. 
After 7 days, animals with fasting blood glucose (FBG) level of more than 
200 mg/dL were considered as diabetic and used for the study [20-22].
Experimental protocol
Nondiabetic rats served as normal group animals, and the diabetic 
animals were grouped into 4 groups of 6 animals each.
Group Treatment
I Normal control (2% acacia)
II Positive control (alloxan 120 mg/kg)
III Standard drug (glibenclamide 0.5 mg/kg)
IV Ethanol extract test dose 200 mg/kg
V Ethanol extract test dose 400 mg/kg
On 0, 7th, 14th, and 21st day, body weight changes and FBG levels of 
animals in all groups were monitored.
Estimation of biochemical parameters
On the 21st day, animals were fasted overnight, anesthetized with 
ether anesthesia and blood was withdrawn from retro-orbital plexus. 
Serum was separated from the blood by centrifugation at 10,000 rpm 
for 10 min (Micro Centrifuge, REMI Motors Ltd, Mumbai) for the 
estimation of various biochemical parameters such as glycosylated 
hemoglobin (HbA1c), triglycerides (TG), total cholesterol (TC), high-
density lipoprotein (HDL), and total protein using reagent kits. Low-
density lipoprotein (LDL) and very low-density lipoprotein (VLDL) 
levels in the serum were derived using Friedewald’s formula:
Low-density lipoprotein (LDL) concentration (mg/dL) = Total 
cholesterol – (HDL cholesterol + Triglycerides/5)
Very low-density lipoprotein (VLDL) concentration (mg/dL) = Triglycerides/5
Further, the animals were sacrificed with thiopental sodium, and 
the liver was isolated for the estimation of malondialdehyde (MDA), 
reduced glutathione and glycogen levels [23,24].
Histopathological studies
All the animals were sacrificed on the 21st day, and necropsy was 
carried out. The pancreases were collected, washed with normal saline 
and kept in 10% formalin solution. Paraffin sections were made at 
5 mm thickness using a microtome processed in alcohol-xylene series. 
It was stained with eosin and hematoxylin, mounted on the glass slide 
for histopathological evaluation.
Oral glucose tolerance test (OGTT)
OGTT was performed in normal rats (Albino Wistar strain) of either 
sex weighing from 200 to 300 g. The animals were divided into 5 
groups consisting of 6 animals each in a group. The animals were 
fasted overnight before the study. During the treatment, Group I 
served as control and received 2% acacia solution (p.o.). Group II 
served as positive control and did not receive any treatment before 
administration of 2 % glucose solution (p.o.). Group III served as 
standard and received 0.5 mg/kg dose of glibenclamide (p.o.). Groups IV 
and V received low and high (200 and 400 mg/kg) doses of ethanol 
extract (p.o.). After 60 min of standard and extract administration, all 
animals were given 2 g/kg body weight of glucose (p.o). Immediately 
blood samples were collected at every 0, 30, 60, 90, and 120 min from 
the tail vein and blood glucose levels were checked using an ACE Blood 
Glucometer [25].
Statistical analysis
The data were expressed as a mean±standard error of the mean values 
and tested with one-way analysis of variance followed by Tukey-Kramer 
multiple comparison tests.
Table 1: Phytochemical screening of C. phlomidis ethanol root 
extract




Fixed oil and fats -




Proteins and amino acids -
+: Present, -: Absent, C. phlomidis: Clerodendrum phlomidis
Fig. 1: Calibration curve of standard gallic acid
Fig. 2: Calibration curve of standard quercetin
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RESULTS
Phytochemical studies
The preliminary phytochemical screening of the ethanol extract of 
C. phlomidis root was shown in Table 1.
Total phenolic and flavonoid content
The calibration curve of gallic acid and quercetin was derived and 
presented in Figs. 1 and 2. The phenolic and flavonoid content of 
ethanol root extract was shown in Table 2.
Acute toxicity study
The acute toxicity study of ethanol extract did not show any toxic 
symptoms or death at 2000 mg/kg dose for up to 15 days. Hence, 
1/5th and 1/10th of the maximum dose tested were selected for the 
evaluation of the antidiabetic activity.
Antidiabetic activity
Effect on body weight and FBG level
The normal and standard treated group animals showed a weight gain 
of 1.67 and 9.5 g, respectively. The extract treated animals at a dose of 
200 and 400 mg/kg showed a significant increase in body weight of 
5.66 and 8.5 g, respectively, whereas positive control group showed a 
weight loss of 17.17 g (Table 3).
On the 0 day, the FBG level of all the experimental animals was 
found to increase after administration of 120 mg/kg dose of alloxan 
monohydrate (i.p.). The animals treated with Glibenclamide 0.5 mg/kg 
showed extremely significant (p<0.001) decrease in FBG level when 
compared to positive control on the 21st day of the study. At 400 mg/kg 
dose, ethanol root extract showed significant (p<0.001) decrease in 
FBG level compared to positive control (Table 4).
Effect on serum biochemical parameters
Lipid profile
Administration of alloxan at a dose of 120 mg/kg caused a significant 
(p<0.001) increase in TC, TG levels, and reduction in HDL levels 
compared to the control group. The diabetic animals treated with 
glibenclamide 0.5 mg/kg showed extremely significant (p<0.001) 
decrease in TC and TG levels in comparison to the positive control group. 
Animals treated with C. phlomidis ethanol root extract at high dose level 
(400 mg/kg) showed extremely significant (p<0.001) decrease in TC 
and TG levels (Table 5).
HbA1c
There was a significant (p<0.001) elevation in HbA1c level in positive 
group animals when compared to control group. Animals treated 
with ethanol extract at both dose levels (200 and 400 mg/kg) showed 
extremely significant (p<0.001) decrease in elevated HbA1c level in 
comparison to positive control group (Table 5).
Table 2: Total phenolic and flavonoid content of ethanol root 
extract of C. phlomidis




Ethanol extract 89.22 61.17
C. phlomidis: Clerodendrum phlomidis, GAE: Gallic acid equivalent
Table 3: Effect of ethanol root extract of C. phlomidis on body weight
Group Treatment Mean initial body weight (g) Mean final body weight (g) Mean weight gain/weight loss (g)
I Normal 255.83±25.82 257.5±25.77 1.67↑
II Positive control 287±22.36 269.83±21.45 17.17↓
III Glibenclamide (0.5 mg/kg) 287.5±22.63 297±24.66 9.5↑
IV Ethanol extract (200 mg/kg) 260±13.33 265.66±17.03 5.66↑
V Ethanol extract (400 mg/kg) 293.66±25.81 302.16±27.57 8.5↑
C. phlomidis: Clerodendrum phlomidis
Table 4: Effect of C. phlomidis on fasting blood glucose in alloxan‑induced diabetic rats
Group Treatment FBG (mg/dl)
0 day 7th day 14th day 21st day
I Normal 89.84±5.54*** 90.82±5.25*** 91.01±5.22*** 91.50±5.12***
II Positive control 213.80±3.48a 214.65±4.38a 215.39±4.04a 216.65±2.58a
III Glibenclamide (0.5 mg/kg) 202.88±2.85*** 187.83±3.30*** 160.74±7.65*** 123.76±3.52***
IV Ethanol extract (200 mg/kg) 206.84±3.16ns 203.64±2.65ns 199.49±1.67ns 187.77±3.89*
V Ethanol extract (400 mg/kg) 207.67±2.80ns 201.77±2.08ns 189.91±1.32** 144.15±6.13***
Values are expressed as mean±SEM and statistically analyzed by one-way ANOVA followed by Turkey Kramer multiple comparison tests. ***p<0.001, **p<0.01, 
*p>0.05, nsp>0.05 in comparison with positive control. ap<0.001 in comparison with normal control. C. phlomidis: Clerodendrum phlomidis, FBG: Fasting blood glucose, 
SEM: Standard error of mean
Table 5: Effect of ethanol root extract of C. phlomidis on serum biochemical parameters
Group Treatment TP (mg/dl) HbA1c (%) TC (mg/dl) TG (mg/dl) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl)
I Normal 9.11±0.13*** 5.58±0.56*** 139.22±1.76*** 72.23±1.24*** 84.03±2.73*** 40.74±2.01*** 14.11±0.25***
II Positive control 4.06±0.82a 9.27±0.56a 187.97±2.53a 168.04±4.00a 48.74±3.73a 104.98±4.17a 33.60±0.79a
III Glibenclamide (0.5 mg/kg) 9.06±0.22*** 6.12±0.08*** 143.94±2.14*** 78.53±3.38*** 80.05±2.73*** 48.18±1.94*** 15.70±0.66***
IV Ethanol extract (200 mg/kg) 4.60±0.25ns 7.2±0.04*** 170.44±4.63** 110.12±6.06*** 64.03±1.34* 84.53±3.31** 22.02±1.21***
V Ethanol extract (400 mg/kg) 8.21±0.19*** 6.31±0.05*** 146.30±1.60*** 81.07±1.81*** 86.59±0.55*** 43.48±1.78*** 16.10±0.45***
Values are expressed as mean±SEM and statistically analyzed by one-way ANOVA followed by Turkey Kramer multiple comparison tests. ***p<0.001, **p<0.01, *p>0.05, 
nsp>0.05 in comparison with positive control. ap<0.001 in comparison with control. C. phlomidis: Clerodendrum phlomidis, TP: Total protein, HbA1c: Glycosylated 
hemoglobin, TC: Total cholesterol, TG: Triglycerides, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, VLDL: Very low-density lipoprotein, SEM: Standard 
error of the mean
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Effect on liver antioxidants levels
The positive control group showed significant (p<0.001) increase in 
MDA and decrease in reduced glutathione levels when compared to 
control group. Administration of ethanol root extract of C. phlomidis for 
21 days at both the dose levels showed extremely significant (p<0.001) 
decrease in MDA level and increase in reduced glutathione level, and 
the values were comparable with standard glibenclamide (0.5 mg/kg) 
(Table 6).
Liver glycogen
There was an extremely significant (p<0.001) decrease in liver glycogen 
levels of positive control animals when compared to vehicle-treated 
group. Treatment of glibenclamide at a dose of 0.5 mg/kg showed 
extremely significant (p<0.001) increase in liver glycogen level in 
comparison to the positive control group. Treatment with ethanol 
extract at dose of 400 mg/kg showed significant (p>0.05) increase in 
liver glycogen level in comparison to positive control (Table 6).
OGTT
Administration of glucose 2 g/kg caused a significant (p<0.001) 
elevation in blood glucose level of the animals at a different time interval 
(0, 30, 60, 90, and 120 min) when compared to the positive control 
group. Treatment with glibenclamide (0.5 mg/kg) significantly (p<0.01; 
p<0.001) lowered the blood glucose level at different time interval in 
comparison to positive control. Groups treated with ethanol extract at 
low- and high-dose level (200 and 400 mg/kg), respectively, showed 
significant (p>0.05; p<0.01; p<0.001) decrease in blood glucose level at 
different time intervals when compared to positive control group. The 
ethanol extract was found to be effective to stimulate the pancreatic 
β cells to secrete insulin after an overdose of glucose maintaining a 
normal blood glucose level (Table 7).
Histopathological studies
The pancreas of control group animals showed lobular cells surrounded 
by islets of Langerhans. The acinar cells are surrounded with intact 
interlobular connective tissue and polygonal cells are arranged 
normally. The pancreas of positive control animals showed congested 
dilated blood vessels and degeneration of islet cells. Glibenclamide 
(standard) treated group pancreas showed regeneration of islets 
cells surrounded by acinar cells. The pancreas of animals treated with 
ethanol extract (200 and 400 mg/kg) showed regeneration of islet cells 
(Fig. 3a-e).
DISCUSSION
Preliminary phytochemical screening of ethanol extract showed the 
presence of alkaloids, carbohydrates, phytosterols, and phenolic 
compounds such as flavonoids and tannins. The ethanol extract was 
found to contain 89.22 mg/g of phenolic and 61.17 mg/g of flavonoid 
content. Acute toxicity study revealed that the extract did not show any 
toxic symptoms at a dose of 2000 mg/kg. Hence, 1/5th and 1/10th of 
the maximum dose administered were selected for the antidiabetic 
study.
Antidiabetic activity of the root extract of C. phlomidis was evaluated by 
alloxan-induced diabetic model. The diabetogenic action of alloxan is 
mainly due to the formation of reactive oxygen species as a result of the 
reduction of alloxan to diuretic acid in the pancreas or due to its potential 
to react with protein SH group of the pancreatic β cells causing cell 
death. The free radicals formed causes cell death by damaging the DNA 
of the β cells leading to induction of Type II diabetes [26]. During the 
study, body weights of the animals were monitored at weekly intervals, 
and it was found that the extract treated groups showed a significant 
increase in body weight when compared to standard. In diabetic 
condition, the body either does not produce insulin or fails to secret or 
use insulin effectively leading to insulin deficiency which causes rapid 
gluconeogenesis. Administration of ethanol extract of C. Phlomidis at a 
higher dose (400 mg/kg) for 21 days showed a significant decrease in 
FBG level when compared to positive control.
Insulin is responsible for lipid metabolism as it inhibits the process of 
lipolysis. In diabetic condition, the action of insulin is altered due to the 
deficiency of insulin causing the release of free fatty acids which undergo 
β-oxidation resulting in increase in TC levels. Insulin deficiency inhibits 
the metabolism of LDL due to a decrease in 3-hydroxy-3-methylglutaryl-
coenzyme A reductase activity. The decrease in enzyme activity leads to 
an increase in LDL concentration giving rise to lipid deposition. Lack of 
insulin also leads to deposition of TGs due to inactivation of the enzyme 
protein lipase responsible for hydrolysis of TGs. Hence, in diabetic 
condition, there is an increase in TC, LDL, TG levels, and decrease in 
HDL level due to metabolic abnormalities [2,21]. The elevated TC, TGs, 
and LDL and VLDL levels in diabetes-induced animals were significant 
decrease in the group treated with 400 mg/kg ethanol root extract of 
C. phlomidis when compared to the positive control animal. The HDL 
levels were also restored to the normal levels in the extract treated 
group.
Table 6: Effect of C. phlomidis on liver antioxidants and glycogen levels
Group Treatment MDA (nmoles/100 mg) Reduced glutathione (nmoles/100 mg) Glycogen (mg/100 mg)
I Normal 0.203±0.03*** 71.18±1.81*** 2.88±0.28***
II Positive control 0.88±0.06a 17.55±1.40a 0.81±0.22a
III Glibenclamide (0.5 mg/kg) 0.337±0.02*** 66.37±0.83*** 2.61±0.24***
IV Ethanol extract (200 mg/kg) 0.529±0.03*** 55.86±3.93*** 1.73±0.09ns
V Ethanol extract (400 mg/kg) 0.324±0.02*** 65.30±1.80*** 2.04±0.12*
Values are expressed as mean±SEM and statistically analyzed by one-way ANOVA followed by Turkey Kramer multiple comparison tests. ***p<0.001, **p<0.01, 
*p>0.05, nsp>0.05 in comparison with positive control. ap<0.001 in comparison with control. SEM: Standard error of the mean, C. phlomidis: Clerodendrum phlomidis, 
MDA: Malondialdehyde
Table 7: Effect of C. phlomidis on OGTT in normal rats
Group Treatment Blood glucose level (mg/dl)
0 min 30 min 60 min 90 min 120 min
I Normal 46.33±1.11*** 64.5±4.08*** 92±1.98 *** 86.33±1.90*** 65.03±4.67***
II Positive control (2 g/kg glucose) 89.83±4.43a 122.83±2.28a 128.66±1.99a 118±2.03a 91.16±2.27a
III Glibenclamide (0.5 mg/kg) 85.16±2.35ns 117.16±2.34** 127.83±2.58** 114.16±2.02*** 88±3.60ns
IV Ethanol extract (200 mg/kg) 71.5±3.18* 78.3±3.14*** 80.66±2.90*** 79.33±2.92*** 75.83±2.57ns
V Ethanol extract (400 mg/kg) 74.16±3.32ns 110±4.76ns 135.83±8.36ns 117.16±8.49** 84.5±5.01ns
Values are expressed as mean±SEM and statistical analysed by one-way ANOVA followed by Turkey Kramer multiple comparison tests. ***p<0.001, **p<0.01, *p>0.05, 
nsp>0.05 in comparison with positive control. ap<0.001 in comparison with control. SEM: Standard error of the mean, C. phlomidis: Clerodendrum phlomidis, OGTT: Oral 
glucose tolerance test
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HbA1c test helps to determine the average blood glucose levels for the 
preceding 3 months. In diabetic condition, high levels of HbA1c are 
observed due to the non-enzymatic reaction between glucose present 
in the plasma and the ß chain. The glucose molecule circulating in the 
blood binds to hemoglobin giving rise to hyperglycemic condition [27]. 
There was a significant decrease in the HbA1c levels in the group 
treated with C. phlomidis ethanol root extract at 400 mg/kg dose in 
comparison to the positive control.
One of the complications of diabetes mellitus is liver damage. Insulin 
resistance may lead to liver damage causing cirrhosis and liver failure. 
MDA is a by-product of lipid peroxidation which helps to detects tissue 
damage caused by the free radical reaction. In diabetic condition, the 
concentration of MDA is decreased due to the free radical formation by 
lipid peroxidation. This causes an increase in oxidative stress as a result 
of high levels of peroxides [28]. MDA levels were restored to normal 
range in the extract treated group at a higher dose of 400 mg/kg and 
comparable with the standard glibenclamide. Reduced glutathione 
is one of the antioxidant enzymes which protect the liver cells from 
oxidative damage. In diabetic condition, the reduced glutathione 
levels are decreased due to increase in oxidative stress caused on the 
liver [26]. The level of reduced glutathione was increased significantly 
in the animals treated with ethanol root extract of C. phlomidis at both 
the doses (200 and 400 mg/kg) when compared to positive control.
Liver also plays a significant role in the regulation of carbohydrate 
metabolism. Glycogen synthesis is impaired in a diabetic condition 
causing accumulation of glycogen in the liver. This occurs due to the 
dysfunction of liver glycogen synthase which leads to abnormalities 
in liver enzyme activity [29]. The group treated with C. phlomidis 
ethanol root extract at a dose of 400 mg/kg showed an increase in the 
liver glycogen level when compared to positive control. The glucose 
tolerance test is done to determine the body’s capability to use glucose. 
This test helps to detect pre-diabetic and diabetic condition [25]. The 
group treated with ethanol extract at a dose of 200 mg/kg showed 
a decrease in blood glucose level between 30 and 90 min whereas 
extract dose of 400 mg/kg significantly decreases the blood glucose 
level only at 90 min. It was found that the root extract of C. phlomidis 
has the potential to lower the blood glucose level after induction of 
hyperglycemia by an overload of glucose.
The antidiabetic activity of C. phlomidis leaf has been reported by 
Gopinathan and Naveenraj [30]. In their study, a marked decrease 
in the levels of biochemical parameters such as blood glucose, liver 
glycogen, and HbA1c was observed which was comparable with the 
standard drug. The findings of the present study correlate with the 
reported antidiabetic activity of C. Phlomidis leaf which substantiates 
the traditional use of C. phlomidis in the treatment of diabetes.
Several studies have corelated the antidiabetic activity of the 
medicinal plants with the presence of phenolic compounds [31,32]. 
The preliminary phytochemical screening showed the presence of 
flavonoids which may be responsible for the antidiabetic activity. 
The extract also showed the presence of alkaloids in the preliminary 
organic analysis which have also been reported to possess antidiabetic 
effect [33,34]. Hence, these phytoconstituents may be responsible for 
the antidiabetic activity of C. Phlomidis root.
CONCLUSION
The present study confirms the antidiabetic activity of ethanol root 
extract of C. phlomidis. The study also substantiates the traditional 
use of C. phlomidis in the treatment of prameha (diabetes mellitus) 
in Ayurveda. Further isolation of active principle responsible for the 
hypoglycemic activity has to be undertaken which will provide a lead 
molecule for the treatment of diabetes.
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(c) diabetic rats treated with Glibenclamide, (d) diabetic rats 
treated with ethanol extract of C. phlomidis (200 mg/kg), and 
(e) diabetic rats treated with ethanol extract of Clerodendrum 
phlomidis (400 mg/kg). IL: Islets of Langerhans, PA: Pancreatic 
cells, CT: Connective tissue, ILD: Interlobular duct, CDBV: Congested 





Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 357-362
 Shanbhag and Radhakrishnan 
8. Yoganarasimhan SN. Medicinal Plants of India (Tamil Nadu). Vol. II. 
Bangalore: Cyber Media; 2000. p. 145.
9. Singh PR. A systematic review on Indian floral biodiversity as eminent 
reserves for alternative treatment strategy of diabetes mellitus. Int J 
Pharm Pharm Sci 2016;8:10-9.
10. Kar MK, Swain TR, Mishra SK. Antidiabetic activity of Clerodendrum 
serratum (L.,) Moon leaves in streptozotocin-induced diabetic rats. 
Asian J Pharm Clin Res 2014;7:260-3.
11. Panigrahi BK, Mishra SK, Sahu SK. Antidiabetic effects of 
Clerodendrum viscosum, vent. World J Pharm Sci 2015;3:1944-8.
12. Panigrahi BK, Mishra SK, Sahu SK. Antidiabetic effects of Clerodendrum 
inerme (L) Gaertn. Int J Pharm Pharm Res 2015;4:248-56.
13. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants 
used in Ayurveda. Vol. 2. New Delhi: Central Council for Research in 
Ayurveda and Siddha, Government of India; 2002. p. 1-7.
14. Jain SK, Rao RR. Field and Herbarium Methods. New Delhi: Today 
and Tomorrow Printers and Publishers; 1976.
15. Harborne JB. Phytochemical Methods. 3rd ed. London: Chapman and 
Hall; 1998. p. 4-7.
16. Kokate CK. Practical Pharmacognosy. New Delhi: Vallabh Prakashan; 
1999. p. 107-11.
17. Chopuhan HS, Singh SK. Phytochemical analysis, antioxidant and 
anti-inflammatory activities of Phyllanthus simplex. J Ethnopharmacol 
2011;137:1337-44.
18. Pourmorad F, Hosseinimehr SJ, Shahabimajd N. Antioxidant activity, 
phenol and flavonoid contents of some selected Iranian medicinal 
plants. Afr J Biotechnol 2006;5:1142-5.
19. Anonymous. OECD Guideline for Testing of Chemicals, OEDC/OCDE 
423; 2001.
20. Asgary S, Rafieian-Kopaei M, Shamsi S, Najafi S, Sahebkar A. 
Biochemical and histopathological study of the anti-hyperglycaemic 
and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in 
alloxan-induced diabetic rats. J Complement Integr Med 2014;11:63-9.
21. Prabu M, Kumuthakalavalli R. Antidiabetic potential of the Oyster 
mushroom Pleurotus florida (Mont.) singer. Int J Curr Pharm Res 
2017;9:51-4.
22. Lachin T, Reza H. Anti-diabetic effect of cherries in alloxan induced 
diabetic rats. Recent Pat Endocr Metab Immune Drug Discov 
2012;6:67-72.
23. Paglia DE, Velentine WN. Studies on the quantitative and qualitative 
characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 
1967;70:159-68.
24. Van Der Vies J. Two methods for the determination of glycogen in liver. 
Biochem J 1954;57:410-6.
25. Sornalakshmi V, Soris T, Paulpriya K, Lincy P, Mohan VR. Oral 
glucose tolerance test (OGTT) in normal control and glucose induced 
hyperglycemic rats with Hedyotis leschenaultiana DC. Int J Toxicol 
Pharmacol Res 2016;8:59-62.
26. Mohamed J, Nafizah NA, Zariyantey AH, Budin SB. Mechanism 
of diabetes-induced liver damage the role of oxidative stress and 
inflammation. Sultan Qaboos Univ Med J 2016;16:132-41.
27. Ananthi J, Prakasam A, Pugalendi KV. Antihyperglycemic activity of 
Eclipta alba leaf on alloxan-induced diabetic rats. Yale J Biol Med 
2004;76:97-102.
28. Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly 
increased levels of serum malondialdehyde in Type 2 diabetics with 
myocardial infraction. Int J Diabetes Dev Ctries 2010;30:49-51.
29. Levinthal GN. Liver diseases and diabetes mellitus. Clin Diabetes 
1999;17:73.
30. Gopinathan S, Naveenraj D. Antidiabetic activity of Clerodendrum 
phlomidis Linn. and Gymnema sylvestre Linn. in alloxan induced 
diabetic rats – A comparative preclinical study. World J Pharm Res 
2014;3:1640-75.
31. Jadhav R, Puchchakayala G. Hypoglycemic and antidiabetic activity 
of flavonoids: Boswellic acid, ellagic acid, Quercetin, Rutin on 
streptozotocin-nicotinamide induced Type 2 diabetic rats. Int J Pharm 
Pharm Sci 2012;4:251-6.
32. Vessal M, Hemmati M, Vasei M. Antidiabetic effect of Quercetin in 
streptozotocin-induced diabetic rats. Comp Biochem Physiol C Toxicol 
Pharmacol 2003;135C:357-64.
33. Gaikwad SB, Mohan GK, Rani MS. Phytochemicals for diabetes 
management. Pharm Corps 2014;5:11-28.
34. Agarwal R, Sethiya NK, Mishra SH. Antidiabetic activity of alkaloids 
of Aerva lanata roots on streptozotocin - Nicotinamide induced Type-II 
diabetes in rats. Pharm Biol 2013;51:635-42.
